LLY Apr 2023 340.000 call
| Previous close | 6.60 |
| Open | 7.40 |
| Bid | 7.20 |
| Ask | 7.60 |
| Strike | 340.00 |
| Expiry date | 2023-04-21 |
| Day's range | 6.43 - 8.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.09k |
- Motley Fool
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
While growth stocks boomed in the era of easy money, value stocks have returned to form as the market's top performers in the current high interest rate environment. Now, value comes in many forms, such as a highly dependable dividend, an economically insensitive revenue stream, the quality of a company's management team, long-term growth drivers, and/or an attractive valuation. In the present risk-averse market, the most highly prized aspects of value stocks appear to be the dependability of a company's dividend, along with its ability to generate strong free cash flows regardless of the state of the broader economy.
- Zacks
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog.
